Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Neomycin Sulfate Tablets

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA Inc NDC 0093-1177-01 D-1473-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 69097-341-35 D-1499-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 76282-708-50 D-1498-2022
Class II · Moderate risk

Triamcinolone Acetonide Cream USP

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Terminated cGMP deviation Padagis US LLC NDC 45802-064-36 D-1497-2022
Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0017-2023
Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0016-2023

Recalls by year